statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) ( Lipella, our , us or the Company ), a clinical-stage biotechnology company addressing serious...

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company's lead candidate, LP-10PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc...

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO  Get Free Report)s share price rose 2.9% during trading on Friday . The stock traded as high as $1.07 and last traded at $1.05. Approximately...

Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 2.9%

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Lipella Pharmaceuticals files $50M mixed securities shelf

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO  Get Free Report)s stock price rose 10.3% during mid-day trading on Thursday . The stock traded as high as $1.12 and last traded at $1.09...

Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 10.3%

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.

Volume	10,020.00
52-Wk High	$2.71
52-Wk Low	$0.64

LIPO Lipella Pharmaceuticals Inc

About

Feed

News

Earnings

Fundamentals